QUANTITATIVE DIFFERENCES BETWEEN COMPLEMENT FACTOR-B PHENOTYPESMORTENSEN JP; LAMM LU.1981; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1981; VOL. 42; NO 4; PP. 505-511; BIBL. 16 REF.Article

CHEMICAL CHARACTERIZATION OF HUMAN FACTOR B OF THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION.CURMAN B; SANDBERG TRAGARDH L; PETERSON PA et al.1977; BIOCHEMISTRY; U.S.A.; DA. 1977; VOL. 16; NO 24; PP. 5368-5375; BIBL. 26 REF.Article

FACTOR B OF THE ALTERNATIVE COMPLEMENT PATHWAY ON HUMAN LYMPHOCYTES.HALBWACHS L; LACHMANN PJ.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 697-704; BIBL. 31 REF.Article

ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY ANTISERUM TO FACTOR BWILSON MR; ARROYAVE CM; TAN EM et al.1979; J. LAB. CLIN. MED.; USA; DA. 1979; VOL. 93; NO 3; PP. 493-498; BIBL. 28 REF.Article

DEVELOPMENTAL ASPECTS OF COMPLEMENT COMPONENTS IN THE NEWBORN. THE PRESENCE OF COMPLEMENT COMPONENTS AND C3 PROACTIVATOR (PROPERDIN FACTOR B) IN HUMAN COLOSTRUMBALLOW M; FANG F; GOOD RA et al.1974; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1974; VOL. 18; NO 2; PP. 257-266; BIBL. 1P.Article

MECHANISM OF ACTION OF FACTOR D OF THE ALTERNATIVE COMPLEMENT PATHWAYLESAVRE PM; MUELLER EBERHARD HJ.1978; J. EXPER. MED.; USA; DA. 1978; VOL. 148; NO 6; PP. 1498-1509; BIBL. 42 REF.Article

GENETIC VARIANTS OF PROPERDIN FACTOR B (BF) IN PAPIO HAMADRYAS BABOONSDYKES DD; CRAWFORD MH; POLESKY HF et al.1981; FOLIA PRIMATOL.; ISSN 0015-5713; CHE; DA. 1981; VOL. 36; NO 3-4; PP. 226-231; BIBL. 15 REF.Article

HAPLOTYPE ANALYSIS OF THE LINKAGE GROUP HLA-A: HLA-B: BF AND ITS BEARING ON THE INTERPRETATION OF THE LINKAGE DISEQUILIBRIUM.BENDER K; MAYEROVA A; FRANK R et al.1977; HUM. GENET.; GERM.; DA. 1977; VOL. 36; NO 2; PP. 191-196; BIBL. 17 REF.Article

BINDING OF COMPONENTS OF THE PROPERDIN SYSTEM TO CULTURED HUMAN LYMPHOBLASTOID CELLS AND B LYMPHOCYTES = FIXATION DE COMPOSANTS DU SYSTEME PROPERDINE A DES CELLULES LYMPHOBLASTOIDES HUMAINES CULTIVEES ET A DES LYMPHOCYTES BTHEOFILOPOULOS AN; PERRIN LH.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 143; NO 2; PP. 271-289; BIBL. 3 P.Article

ON THE LOCALIZATION OF THE GB LOCUS WITHIN THE MHS REGION OF CHROMOSOME NO. 6TEISBERG P; OLAISEN B; GEDDE DAHL T JR et al.1975; TISSUE ANTIGENS; DENM.; DA. 1975; VOL. 5; NO 4; PP. 257-261; BIBL. 8 REF.Article

Nomenclature for human complement factor B : WHO-IUIS nomenclature sub-committeeJournal of immunological methods. 1993, Vol 163, Num 1, pp 9-11, issn 0022-1759Article

An unusual Morphologic variant of BP SRAUM, D; SURGENOR, T; AWDEH, Z et al.American journal of human genetics. 1984, Vol 36, Num 2, pp 346-351, issn 0002-9297Article

GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article

SYNTHESIS OF FACTORS D, B AND P OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION, AS WELL AS OF C3, BY GUINEA-PIG PERITONEAL MACROPHAGES IN VITROBENTLEY C; FRIES W; BRADE V et al.1978; IMMUNOLOGY; GBR; DA. 1978; VOL. 35; NO 6; PP. 971-980; BIBL. 24 REF.Article

Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMAILLET, F; KAZATCHKINE, M. D; GLOTZ, D et al.Molecular immunology. 1983, Vol 20, Num 12, pp 1401-1404, issn 0161-5890Article

BF-IMMUNFIXATION AUF CELLOGEL-FOLIEN = IMMUNOFIXATION DU FACTEUR BF SUR MEMBRANE DE CELLOGELMARTIN W; ZIEGLER C.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 42; NO 1; PP. 23-26; ABS. ENG; BIBL. 7 REF.Article

A NEW RARE PHENOTYPE OF GLYCINE-RICH BETA -GLYCOPROTEINSCHERZ R; PFLUGSHAUPT R; BUTLER R et al.1978; HUM. GENET.; DEU; DA. 1978; VOL. 45; NO 1; PP. 81-83; BIBL. 7 REF.Article

THE LOCALIZATION OF THE BF LOCUS WITHIN THE MHS REGION ON CHROMOSOME NO 6HAUPTMANN G; SASPORTES M; TONGIO MM et al.1976; TISSUE ANTIGENS; DENM.; DA. 1976; VOL. 7; NO 1; PP. 52-54; BIBL. 6 REF.Article

ACTIVATION OF TERMINAL COMPONENTS OF HUMAN COMPLEMENT BY A TRYPSIN-ACTIVATED COMPLEX OF HUMAN FACTOR B AND COBRA VENON FACTOR.MIYAMA A; KATO T; MINODA I et al.1976; JAP. J. MICROBIOL.; JAP.; DA. 1976; VOL. 20; NO 6; PP. 507-516; BIBL. 21 REF.Article

AGE AT ONSET OF INSULIN-DEPENDENT DIABETES MELLITUS ASSOCIATED WITH BFF1BUDOWLE B; LOUV WC; BARGER BO et al.1983; IMMUNOGENETICS (NEW YORK); ISSN 0093-7711; DEU; DA. 1983; VOL. 17; NO 4; PP. 437-440; BIBL. 13 REF.Article

A NOTE ON ASSOCIATION OF BF AND GLOMERULONEPHRITISPAPIHA SS; RASHID HU; ROBERTS DF et al.1982; CLIN. GENET.; ISSN 0009-9163; DNK; DA. 1982; VOL. 22; NO 2; PP. 67-69; BIBL. 13 REF.Article

THE BINDING OF HUMAN COMPLEMENT PROTEINS C5, FACTOR B, BETA ₁H AND PROPERDIN TO COMPLEMENT FRAGMENT C3B ON ZYMOSANDISCIPIO RG.1981; BIOCHEM. J. (LOND.); ISSN 0006-2936; GBR; DA. 1981; VOL. 199; NO 3; PP. 485-496; BIBL. 54 REF.Article

ACTIVATED FACTOR B (BB) OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION CLEAVES AND ACTIVATES PLASMINOGENSUNDSMO JS; WOOD LM.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 127; NO 3; PP. 877-880; BIBL. 34 REF.Article

ISOLATION AND CHARACTERIZATION OF RAT COMPLEMENT FACTOR B AND ITS INTERACTION WITH CELL-BOUND HUMAN C3DAHA MR; VAN ES LA.1980; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1980; VOL. 41; NO 4; PP. 849-855; BIBL. 20 REF.Article

MURINE FACTOR B: ELECTROPHORETIC POLYMORPHISM.RUBINSTEIN P; ROSENFIELD STEELE P; DAY NK et al.1977; IMMUNOGENETICS; GERM.; DA. 1977; VOL. 5; NO 4; PP. 363-366; BIBL. 15 REF.Article